CD248 Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6756b
Background:
CD248 is believed to play a role in tumor angiogenesis. CD248 is being investigated as a potential target for cancer treatment.
Other Names:
Endosialin, Tumor endothelial marker 1, CD248, CD248, CD164L1, TEM1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6756b was selected from the C-term region of human CD248. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CD248
Gene ID: 57124
Primary Accession: Q9HCU0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
CD248 is believed to play a role in tumor angiogenesis. CD248 is being investigated as a potential target for cancer treatment.
Other Names:
Endosialin, Tumor endothelial marker 1, CD248, CD248, CD164L1, TEM1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6756b was selected from the C-term region of human CD248. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CD248
Gene ID: 57124
Primary Accession: Q9HCU0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review